<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<GBSeq>
  <GBSeq_locus>FB654917</GBSeq_locus>
  <GBSeq_length>900</GBSeq_length>
  <GBSeq_strandedness>double</GBSeq_strandedness>
  <GBSeq_moltype>DNA</GBSeq_moltype>
  <GBSeq_topology>linear</GBSeq_topology>
  <GBSeq_division>PAT</GBSeq_division>
  <GBSeq_update-date>01-NOV-2008</GBSeq_update-date>
  <GBSeq_create-date>01-NOV-2008</GBSeq_create-date>
  <GBSeq_definition>Sequence 1 from Patent EP1876173</GBSeq_definition>
  <GBSeq_primary-accession>FB654917</GBSeq_primary-accession>
  <GBSeq_accession-version>FB654917.1</GBSeq_accession-version>
  <GBSeq_other-seqids>
    <GBSeqid>emb|FB654917.1|</GBSeqid>
    <GBSeqid>pat|EP|1876173|1</GBSeqid>
    <GBSeqid>gi|211653320</GBSeqid>
  </GBSeq_other-seqids>
  <GBSeq_source>Hepatitis C virus</GBSeq_source>
  <GBSeq_organism>Hepatitis C virus</GBSeq_organism>
  <GBSeq_taxonomy>Viruses; ssRNA viruses; ssRNA positive-strand viruses, no DNA stage; Flaviviridae; Hepacivirus</GBSeq_taxonomy>
  <GBSeq_references>
    <GBReference>
      <GBReference_reference>1</GBReference_reference>
      <GBReference_authors>
        <GBAuthor>Babine,R.E.</GBAuthor>
        <GBAuthor>Chen,S.H.</GBAuthor>
        <GBAuthor>Lamar,J.E.</GBAuthor>
        <GBAuthor>Snyder,N.J.</GBAuthor>
        <GBAuthor>Sun,X.</GBAuthor>
        <GBAuthor>Tebbe,M.J.</GBAuthor>
        <GBAuthor>Victor,F.</GBAuthor>
        <GBAuthor>Wang,M.Q.</GBAuthor>
        <GBAuthor>Yip,M.Y.</GBAuthor>
        <GBAuthor>Collado,I.</GBAuthor>
        <GBAuthor>Garcia-Paredes,C.</GBAuthor>
        <GBAuthor>Parker III,S.R.</GBAuthor>
        <GBAuthor>Jin,L.</GBAuthor>
        <GBAuthor>Duo,D.</GBAuthor>
        <GBAuthor>Glass,J.I.</GBAuthor>
      </GBReference_authors>
      <GBReference_title>Chiral intermediates for the preparation of peptidomimetic protease inhibitors</GBReference_title>
      <GBReference_journal>Patent: EP 1876173-A 1 09-JAN-2008; VERTEX PHARMACEUTICALS INCORPORATED (US)</GBReference_journal>
    </GBReference>
  </GBSeq_references>
  <GBSeq_feature-table>
    <GBFeature>
      <GBFeature_key>source</GBFeature_key>
      <GBFeature_location>1..900</GBFeature_location>
      <GBFeature_intervals>
        <GBInterval>
          <GBInterval_from>1</GBInterval_from>
          <GBInterval_to>900</GBInterval_to>
          <GBInterval_accession>FB654917.1</GBInterval_accession>
        </GBInterval>
      </GBFeature_intervals>
      <GBFeature_quals>
        <GBQualifier>
          <GBQualifier_name>organism</GBQualifier_name>
          <GBQualifier_value>Hepatitis C virus</GBQualifier_value>
        </GBQualifier>
        <GBQualifier>
          <GBQualifier_name>mol_type</GBQualifier_name>
          <GBQualifier_value>unassigned DNA</GBQualifier_value>
        </GBQualifier>
        <GBQualifier>
          <GBQualifier_name>db_xref</GBQualifier_name>
          <GBQualifier_value>taxon:11103</GBQualifier_value>
        </GBQualifier>
      </GBFeature_quals>
    </GBFeature>
  </GBSeq_feature-table>
  <GBSeq_sequence>gtgcttgcgagtgccccgggaggtctcgtagaccgtgcaccatgagcacgaatcctaaacctcaaagaaaaaccaaacgtaacaccaacgggcgcgccatgattgaacaagatggattgcacgcaggttctccggccgcttgggtggagaggctattcggctatgactgggcacaacagacaatcggctgctctgatgccgccgtgttccggctgtcagcgcaggggcgcccggttctttttgtcaagaccgacctgtccggtgccctgaatgaactgcaggacgaggcagcgcggctatcgtggctggccacgacgggcgttccttgcgcagctgtgctcgacgttgtcactgaagcgggaagggactggctgctattgggcgaagtgccggggcaggatctcctgtcatctcaccttgctcctgccgagaaagtatccatcatggctgatgcaatgcggcggctgcatacgcttgatccggctacctgcccattcgaccaccaagcgaaacatcgcatcgagcgagcacgtactcggatggaagccggtcttgtcgatcaggatgatctggacgaagagcatcaggggctcgcgccagccgaactgttcgccaggctcaaggcgcgcatgcccgacggcgaggatctcgtcgtgacccatggcgatgcctgcttgccgaatatcatggtggaaaatggccgcttttctggattcatcgactgtggccggctgggtgtggcggaccgctatcaggacatagcgttggctacccgtgatattgctgaagagcttggcggcgaatgggctgaccgcttcctcgtgctttacggtatcgccgctcccgattcgcagcgcatcgccttctatcgccttcttgacgagttcttctgagtttaaa</GBSeq_sequence>
</GBSeq>
